Congratulations to Associate Dean for Research, Innovation & Impact Dr Alison Reynolds and her team at OcuHealth, which was named overall winner in NovaUCD's UCD 2025 VentureLaunch Accelerator Programme, which is focused on supporting the creation and launch of new start-ups emerging from UCD.
OcuHealth is developing novel formulations to treat eye disease. OcuHealth’s groundbreaking “once a day” eye drop can deliver conventional small molecules and large biomolecules, in a slow and sustained manner, to all parts of the eye, substantially improving on current treatment options.
OcuHealth, a joint UCD and South East Technological University (SETU) project, has received €700k in funding through the Enterprise Ireland Commercialisation Fund, and is being supported by technology transfer offices at SETU and NovaUCD.
Other team members of OcuHealth include, Dr Laurence Fitzhenry, Head of Faculty, Science and Computing (Waterford) and Principal Investigator of the Ocular Therapeutics Research Group, SETU, Dr Muhammad Sarfraz, Department of Science, SETU and commercial lead, John Lynch.
Dr Reynolds said, "I would like to acknowledge the excellent support provided by NovaUCD, the VentureLaunch programme facilitators, and particularly the other VentureLaunch participants, especially for their invaluable feedback and advice received throughout the programme.”
The news was covered by (opens in a new window)The Business Post, (opens in a new window)Business Plus, (opens in a new window)Think Business and (opens in a new window)Tech Central.